Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) — Net Asset Momentum
Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) recorded a net asset momentum of 6.3% as of December 2025, with net assets of CN¥6.90 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Nanjing King-friend Biochemical Pharmace (603707) net assets for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Nanjing King-friend Biochemical Pharmaceutical Co Ltd Net Asset Momentum (2013–2025)
This chart tracks Nanjing King-friend Biochemical Pharmaceutical Co Ltd's year-over-year net asset growth across 13 annual reporting periods from 2013 to 2025. The most recent momentum reading is +6.3%, with net assets of CN¥6.90 Billion CNY as of December 2025. For live market cap and overall valuation, see market value of Nanjing King-friend Biochemical Pharmace.
Annual Net Asset History for Nanjing King-friend Biochemical Pharmaceutical Co Ltd (2013–2025)
The table below shows the complete annual net asset history for Nanjing King-friend Biochemical Pharmaceutical Co Ltd from 2013 to 2025, covering 13 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check tangible net worth ratio of Nanjing King-friend Biochemical Pharmace to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥6.90 Billion | CN¥10.34 Billion | CN¥3.44 Billion | ▲ +6.3% |
| 2024 | CN¥6.49 Billion | CN¥9.51 Billion | CN¥3.02 Billion | ▲ +11.9% |
| 2023 | CN¥5.80 Billion | CN¥9.52 Billion | CN¥3.73 Billion | ▼ -6.0% |
| 2022 | CN¥6.17 Billion | CN¥10.01 Billion | CN¥3.84 Billion | ▲ +14.1% |
| 2021 | CN¥5.40 Billion | CN¥8.22 Billion | CN¥2.81 Billion | ▲ +44.3% |
| 2020 | CN¥3.74 Billion | CN¥7.72 Billion | CN¥3.98 Billion | ▲ +24.6% |
| 2019 | CN¥3.00 Billion | CN¥5.08 Billion | CN¥2.07 Billion | ▲ +24.1% |
| 2018 | CN¥2.42 Billion | CN¥3.40 Billion | CN¥981.21 Million | ▲ +18.0% |
| 2017 | CN¥2.05 Billion | CN¥2.69 Billion | CN¥642.50 Million | ▲ +56.1% |
| 2016 | CN¥1.31 Billion | CN¥1.52 Billion | CN¥208.09 Million | ▲ +20.3% |
| 2015 | CN¥1.09 Billion | CN¥1.30 Billion | CN¥204.72 Million | ▲ +5.9% |
| 2014 | CN¥1.03 Billion | CN¥1.54 Billion | CN¥508.26 Million | ▲ +1.3% |
| 2013 | CN¥1.02 Billion | CN¥1.16 Billion | CN¥138.91 Million | — |